September 19, 2024

Patients Suffer as Dea Unexplained Delays MMJ’s Marijuana Research, Clinical Trials, and Pharmaceutical Development

 Patients Suffer as Dea Unexplained Delays MMJ’s Marijuana Research, Clinical Trials, and Pharmaceutical Development

PROVIDENCE, RI / ACCESSWIRE / September 6, 2022 / Duane Boise, MMJ companies President echoing the NIH directors recent statements remarked, “Unfortunately MMJ was forced to file suit against the DEA…